ARCHIVES

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

This article is from The Cancer Letter archive.

Vol. 15 No. 42 | November 3, 1989

Download PDF Visit The Full Archive

Related Articles

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

Clinical Trials Working Group Offers 21 Recommendations to improve efficiency of trials.

February 25, 2005

Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million.

December 9, 2005

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

RFPs Available, Contract Awards, Sole Source Negotiations

June 25, 1976